Weekly Investment Analysts’ Ratings Updates for BrightSpring Health Services (BTSG)

A number of research firms have changed their ratings and price targets for BrightSpring Health Services (NASDAQ: BTSG):

• 3/19/2026 – BrightSpring Health Services had its “buy” rating reaffirmed by BTIG Research. They now have a $55.00 price target on the stock.
• 3/18/2026 – BrightSpring Health Services had its “outperform” rating reaffirmed by Leerink Partners. They now have a $49.00 price target on the stock.
• 3/18/2026 – BrightSpring Health Services had its price target raised by UBS Group AG from $53.00 to $55.00. They now have a “buy” rating on the stock.
• 3/18/2026 – BrightSpring Health Services had its price target raised by Mizuho from $50.00 to $52.00. They now have an “outperform” rating on the stock.
• 3/4/2026 – BrightSpring Health Services had its price target raised by Morgan Stanley from $40.00 to $48.00. They now have an “overweight” rating on the stock.
• 3/3/2026 – BrightSpring Health Services was upgraded by Zacks Research from “hold” to “strong-buy”.
• 3/3/2026 – BrightSpring Health Services had its price target raised by Mizuho from $45.00 to $50.00. They now have an “outperform” rating on the stock.
• 3/2/2026 – BrightSpring Health Services was given a new $49.00 price target by Cantor Fitzgerald.
• 3/2/2026 – BrightSpring Health Services had its “buy” rating reaffirmed by TD Cowen.
• 3/2/2026 – BrightSpring Health Services had its “buy” rating reaffirmed by BTIG Research. They now have a $55.00 price target on the stock.
• 3/2/2026 – BrightSpring Health Services had its price target raised by Wells Fargo & Company from $43.00 to $50.00. They now have an “overweight” rating on the stock.
• 2/2/2026 – BrightSpring Health Services had its price target raised by BTIG Research from $50.00 to $55.00. They now have a “buy” rating on the stock.
• 1/27/2026 – BrightSpring Health Services had its “buy” rating reaffirmed by TD Cowen.

Insider Transactions at BrightSpring Health Services

In other news, CFO Jennifer A. Phipps sold 35,000 shares of the firm’s stock in a transaction that occurred on Wednesday, March 4th. The shares were sold at an average price of $41.15, for a total value of $1,440,250.00. Following the completion of the transaction, the chief financial officer owned 196,840 shares of the company’s stock, valued at approximately $8,099,966. This trade represents a 15.10% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Jon B. Rousseau sold 220,000 shares of BrightSpring Health Services stock in a transaction that occurred on Wednesday, March 4th. The shares were sold at an average price of $41.15, for a total transaction of $9,053,000.00. Following the completion of the transaction, the insider owned 1,023,880 shares of the company’s stock, valued at $42,132,662. This trade represents a 17.69% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders have sold 285,000 shares of company stock valued at $11,727,750. 3.40% of the stock is currently owned by corporate insiders.

BrightSpring Health Services (NASDAQ: BTSG) is a leading provider of home and community-based care and workforce solutions aimed at seniors, individuals with disabilities and those facing behavioral health challenges. The company’s operations encompass a broad spectrum of services, including personal care, skilled nursing, therapy, habilitation and supported living, as well as specialized behavioral health programs delivered through both clinical and non-clinical channels.

Through its network of subsidiary brands, BrightSpring offers integrated care in the patient’s home environment, fostering independence and improving quality of life.